PubRank

D Giugliano

Author PubWeight™ 155.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficacy and safety of intravenous midazolam and ketamine as sedation for therapeutic and diagnostic procedures in children. Pediatrics 1997 15.08
2 Impairment of insulin secretion in man by nifedipine. Eur J Clin Pharmacol 1980 2.22
3 The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000 1.86
4 Oxidative stress and insulin action: is there a relationship? Diabetologia 1996 1.86
5 The metabolic syndrome: a cause of sexual dysfunction in women. Int J Impot Res 2005 1.50
6 Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am J Clin Nutr 2001 1.49
7 Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004 1.48
8 Association of body weight with sexual function in women. Int J Impot Res 2007 1.43
9 Pregnancy as environmental factor precipitating IDDM. Diabetes Care 1989 1.43
10 Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999 1.42
11 Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon. Thromb Haemost 1990 1.40
12 Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002 1.38
13 Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010 1.38
14 Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010 1.36
15 Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000 1.27
16 Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 2001 1.23
17 Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2009 1.18
18 Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. Am J Physiol 1998 1.15
19 Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab 1991 1.15
20 Proportion of patients at HbA1c target <7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78 945 patients. Diabetes Obes Metab 2011 1.14
21 Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug? Ann Intern Med 1990 1.14
22 Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993 1.14
23 Dipeptidyl peptidase-4 inhibitors and HbA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Obes Metab 2011 1.14
24 Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet Med 2010 1.13
25 Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 1991 1.12
26 Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005 1.11
27 Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 2000 1.10
28 Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men. J Endocrinol Invest 2004 1.09
29 Acute hyperglycemia and autonomic function. Diabetes Care 2001 1.07
30 Impaired glucose metabolism in heroin and methadone users. Horm Metab Res 1987 1.07
31 Influence of acetylsalicylic acid on glucose turnover in normal man. Diabete Metab 1982 1.06
32 Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol 1995 1.06
33 Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest 2013 1.04
34 Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 2001 1.02
35 Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994 1.02
36 Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes. Metabolism 1983 1.01
37 The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004 1.01
38 The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia 1978 0.99
39 Effect of metformin on food intake in obese subjects. Eur J Clin Invest 1998 0.99
40 Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia 1998 0.98
41 Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol 1994 0.98
42 High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetologia 2001 0.98
43 Resting metabolic rate and respiratory quotient in human longevity. J Clin Endocrinol Metab 2004 0.97
44 Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients. Diabetes Care 1993 0.96
45 Obesity and sexual dysfunction, male and female. Int J Impot Res 2008 0.95
46 New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 1992 0.95
47 Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 2010 0.94
48 Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia 1986 0.93
49 Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006 0.93
50 Metabolic control may influence the increased superoxide generation in diabetic serum. Diabet Med 1991 0.92
51 Diabetes mellitus and hypertension: the possible role of hyperglycaemia through oxidative stress. Diabetologia 1993 0.91
52 Oxidative stress in the metabolic syndrome. J Endocrinol Invest 2006 0.90
53 Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest 2002 0.90
54 Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial. Diabetes Obes Metab 2011 0.90
55 Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 1999 0.89
56 Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988 0.88
57 Increased glycosylated haemoglobin A1 in opiate addicts: evidence for a hyperglycaemic effect of morphine. Diabetologia 1982 0.87
58 Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients. Diabetologia 2004 0.87
59 Acetyl-L-carnitine for symptomatic diabetic neuropathy. Diabetologia 1995 0.87
60 Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2006 0.87
61 Evidence for peripheral impaired glucose handling in patients with connective tissue diseases. Metabolism 1991 0.87
62 Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care 1992 0.87
63 Obesity, the metabolic syndrome, and sexual dysfunction in men. Clin Pharmacol Ther 2011 0.87
64 Morphine, opioid peptides, and pancreatic islet function. Diabetes Care 1984 0.86
65 Lifestyle and metabolic approaches to maximizing erectile and vascular health. Int J Impot Res 2011 0.86
66 GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Curr Med Res Opin 2011 0.86
67 Pharmacokinetic-pharmacodynamic relationships of Acarbose. Clin Pharmacokinet 1996 0.86
68 Role of free fatty acids on cardiac autonomic nervous system in noninsulin-dependent diabetic patients: effects of metabolic control. J Clin Endocrinol Metab 2001 0.86
69 Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care 1996 0.85
70 Mediterranean diet improves sexual function in women with the metabolic syndrome. Int J Impot Res 2007 0.84
71 Effects of pioglitazone versus metformin on circulating endothelial microparticles and progenitor cells in patients with newly diagnosed type 2 diabetes--a randomized controlled trial. Diabetes Obes Metab 2011 0.84
72 Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) 1991 0.84
73 Influence of ozone on haemoglobin oxygen affinity in type-2 diabetic patients with peripheral vascular disease: in vitro studies. Diabete Metab 1995 0.84
74 Depressed antithrombin III biological activity in opiate addicts. J Clin Pathol 1984 0.83
75 Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. J Clin Endocrinol Metab 1988 0.82
76 Obesity, cytokines and endothelial dysfunction: a link for the raised cardiovascular risk associated with visceral obesity. J Endocrinol Invest 2002 0.82
77 Elevated post-prandial free fatty acids are associated with cardiac sympathetic overactivity in Type II diabetic patients. Diabetologia 2002 0.82
78 Opiate addict as diabetic patient? Diabetes Care 1988 0.81
79 Glycosylated haemoglobin and reticulocyte count in diabetes. Diabetologia 1982 0.81
80 Prostaglandin E1 inhibits glucose-induced insulin secretion in man. Prostaglandins Med 1978 0.81
81 Glycosaminoglycans in human diabetes. Diabete Metab 1983 0.81
82 Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985 0.81
83 Bumetanide and glucose tolerance in man. Farmaco Prat 1980 0.81
84 The squatting test. A useful tool to assess both parasympathetic and sympathetic involvement of the cardiovascular autonomic neuropathy in diabetes. Diabetes 1994 0.81
85 A possible role of gamma-aminobutyric acid in the control of the endocrine pancreas. J Clin Endocrinol Metab 1982 0.80
86 Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care 1984 0.80
87 Hyperglycemia counterbalances the antihypertensive effect of glutathione in diabetic patients: evidence linking hypertension and glycemia through the oxidative stress in diabetes mellitus. J Diabetes Complications 1997 0.80
88 Thrombocytopenia in heroin users. Blood 1982 0.80
89 Adrenergic control of basal insulin and glucose in the rat. Farmaco Prat 1977 0.80
90 Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans. Diabetologia 1990 0.80
91 Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects. Diabete Metab 1992 0.80
92 L-arginine but not D-arginine stimulates insulin-mediated glucose uptake. Metabolism 1997 0.80
93 Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes 1982 0.80
94 Induced hyperglycemia alters antithrombin III activity but not its plasma concentration in healthy normal subjects. Diabetes 1987 0.79
95 Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non insulin-dependent diabetic subjects. Metabolism 1987 0.79
96 Further studies on the significance of circulating platelet aggregates induced by somatostatin in man. Metabolism 1981 0.79
97 Dietary factors in erectile dysfunction. Int J Impot Res 2006 0.79
98 Haemoglobin A1 in addicts. Ann Intern Med 1982 0.79
99 Acetylsalicyclic acid restores acute insulin response reduced by furosemide in man. Diabetes 1979 0.79
100 Is there a role for chloroquine treatment in diabetes? A three case report. Diabete Metab 1989 0.79
101 Hyperglycemia and QT interval: time for re-evaluation. Diabetes Nutr Metab 2001 0.79
102 The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabet Med 1990 0.79
103 Glycemic control with an artificial pancreas improves insulin responses to both oral and glucose in nonobese noninsulin-dependent diabetic subjects. Acta Diabetol Lat 1986 0.79
104 Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. Acta Endocrinol (Copenh) 1987 0.79
105 Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylation. Diabetes Care 1986 0.79
106 Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients. Atherosclerosis 2000 0.79
107 A role for endogenous prostaglandin E in biphasic pattern of insulin release in humans. Am J Physiol 1983 0.79
108 Simvastatin normalizes qtc dispersion and reduces ventricular electrical instability in isolated hypercholesterolemia. J Endocrinol Invest 2002 0.79
109 Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type 1) diabetic subjects. Horm Res 1989 0.79
110 Decreased insulin clearance as a feature of essential hypertension. J Clin Endocrinol Metab 1992 0.79
111 Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity. Acta Diabetol Lat 1989 0.78
112 Chronic intake of pharmacological doses of vitamin E might be useful in the therapy of elderly patients with coronary heart disease. Am J Clin Nutr 1995 0.78
113 Effect of calcitonin on insulin response to arginine in man. Diabete Metab 1979 0.78
114 Impaired insulin response to glucose but not to arginine in heroin addicts. J Endocrinol Invest 1986 0.78
115 Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide. Diabete Metab 1993 0.78
116 Calcitonin in painful diabetic neuropathy. Lancet 1992 0.78
117 Hypertension in the elderly is associated with impaired glucose metabolism independently of obesity and glucose intolerance. J Hypertens Suppl 1988 0.78
118 Interleukin-20 circulating levels in obese women: effect of weight loss. Nutr Metab Cardiovasc Dis 2009 0.78
119 Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin dependent diabetes. Diabete Metab 1991 0.78
120 Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation. Diabete Metab 1987 0.78
121 Peripheral diabetic neuropathy. Current recommendations and future prospects for its prevention and management. Drugs 1997 0.77
122 Effect of citric acid crosslinking cellulose-based hydrogels on osteogenic differentiation. J Biomed Mater Res A 2014 0.77
123 Height and glucose tolerance. Diabetologia 1992 0.77
124 Impaired insulin secretion in human diabetes mellitus. I. The effect of alpha-adrenergic inhibition. Pharmacol Res Commun 1982 0.77
125 Possible role for increased C4b-binding-protein level in acquired protein S deficiency in type I diabetes. Diabetes 1990 0.77
126 Pharmacological doses of oxytocin affect plasma hormone levels modulating glucose homeostasis in normal man. Horm Res 1988 0.77
127 Simultaneous control of hyperglycemia and oxidative stress normalizes enhanced thrombin generation in type 1 diabetes. J Thromb Haemost 2009 0.77
128 Glucose utilization from dialysate in patients on continuous ambulatory peritoneal dialysis (CAPD). Int J Artif Organs 1979 0.77
129 Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women. J Endocrinol Invest 2003 0.77
130 Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM. Diabetes Care 1994 0.77
131 Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins. J Intern Med 2004 0.77
132 Calcitonin modulation of insulin and glucagon secretion in man. Am J Physiol 1982 0.77
133 Pizza and vegetables don't stick to the endothelium. Circulation 2001 0.77
134 The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people. J Clin Endocrinol Metab 1996 0.77
135 Effect of insulin on blood rheology in non-diabetic subjects and in patients with Type 2 diabetes mellitus. Diabet Med 1997 0.77
136 Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1988 0.76
137 Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 1989 0.76
138 Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Diabete Metab 1980 0.76
139 Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. Pituitary 2014 0.76
140 The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects. J Clin Endocrinol Metab 2001 0.76
141 Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins. Prostaglandins Med 1981 0.76
142 Mediterranean diet and prevention of coronary heart disease. J Endocrinol Invest 2002 0.76
143 Mean arterial blood pressure and serum levels of the molar ratio of insulin-like growth factor-1 to its binding protein-3 in healthy centenarians. J Hypertens 1999 0.76
144 Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up. Diabete Metab 1986 0.76
145 Hyperglycemia and heart dysfunction: an oxidant mechanism contributing to heart failure in diabetes. J Endocrinol Invest 2002 0.76
146 Analysis of diabetic family connection in subjects with insulin-dependent diabetes mellitus (IDDM). Diabete Metab 1991 0.76
147 Effects of oxytocin upon the endocrine pancreas secretion and glucose turnover in normal man. Acta Endocrinol (Copenh) 1990 0.75
148 Hypertension and ascorbic acid. Lancet 2000 0.75
149 Combination therapy in NIDDM. Diabetes Care 1993 0.75
150 Which diet is best for diabetes? Diabetologia 2009 0.75
151 Stress hyperglycaemia and death after myocardial infarction. Lancet 2000 0.75
152 Prostaglandins and the alpha-cell. Prostaglandins Med 1981 0.75
153 QTc dispersion, hyperglycemia, and hyperinsulinemia. Circulation 1999 0.75
154 Endogenous opiates, heroin addiction, and non-insulin-dependent diabetes. Lancet 1985 0.75
155 Relationship of baseline HbA1c and HbA1c reduction following insulin therapy in Type 2 diabetes. Diabet Med 2011 0.75
156 Hyperglycemia leads to ECG reevaluation. Aging (Milano) 2000 0.75
157 Respiratory function in IDDM patients. Diabetes Care 1993 0.75
158 Prostaglandin E1 increases basal glucagon in man. Pharmacol Res Commun 1978 0.75
159 Systematic hormonal investigations in reactive hypoglycemia. A report of three cases. Panminerva Med 1981 0.75
160 Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus. J Clin Endocrinol Metab 1987 0.75
161 Effects of surgical menopause and estrogen replacement therapy on atrio-ventricular conduction and ventricular repolarization. Maturitas 2001 0.75
162 Oxytocin increases arginine-induced A and B cell secretion in normal man and in diabetic subjects. Diabete Metab 1988 0.75
163 Calcitonin in diabetes. Lancet 1980 0.75
164 Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects. Acta Diabetol Lat 1981 0.75
165 Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin. Metabolism 1995 0.75
166 Glycosylated proteins as an indicator of metabolic control in diabetes: evaluation by aminophenylboronic acid affinity chromatography. Acta Diabetol Lat 1984 0.75
167 Evidence for a reduced heparin cofactor II biological activity in diabetes. Haemostasis 1990 0.75
168 Mean red blood cell volume, narcotic addiction, and glucose tolerance. Arch Intern Med 1985 0.75
169 The combined insulin and sulfonylurea therapy in diabetes of elderly people. Arch Gerontol Geriatr 2004 0.75
170 [Acetylsalicylic acid and hormonal response in insulin induced hypoglycemia]. Boll Soc Ital Biol Sper 1979 0.75
171 Influence of acetylsalicylic acid on plasma glucose, insulin, glucagon, and growth hormone levels following tolbutamide stimulation in man. Metabolism 1979 0.75
172 The effects of salbutamol on some metabolic and endocrine patterns of diabetic subjects. Pharmacol Res Commun 1980 0.75
173 Increased alpha-2-macroglobulin in opiate addicts: further evidence of an alteration in the coagulation system due to opiate addiction. Acta Haematol 1985 0.75
174 Increased beta-thromboglobulin levels in heroin addicts. Thromb Haemost 1985 0.75
175 In vivo and in vitro experiments on relationships between PGA1 and glucose utilization. Acta Diabetol Lat 1976 0.75
176 Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus. J Clin Endocrinol Metab 1987 0.75
177 Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man. Diabete Metab 1978 0.75
178 [Opioid peptides and glucose metabolism]. Rev Med Liege 1987 0.75
179 [Effect of circulating insulin on liver damage by CCl4 in the rat. I. Biochemical studies]. Boll Soc Ital Biol Sper 1980 0.75
180 The toxic trio: acute, chronic, and post-prandial hyperglycemia. Nutr Metab Cardiovasc Dis 2001 0.75
181 Effect of calcitonin on glucose--stimulated insulin secretion in normal, obese and prediabetic subjects. Farmaco Prat 1978 0.75
182 A preliminary note on inhibiting effect of alpha-tocopherol (vit. E) on protein glycation. Diabete Metab 1988 0.75
183 Isolated fatty change of liver as marker of glucose intolerance. Diabetes Care 1992 0.75
184 A comparative study of metabolic and hormonal responses to somatostatin and propranolol in man. Acta Diabetol Lat 1979 0.75
185 [Effects of some oral hypoglycemia drugs on blood levels of lactic and pyruvic acid in diabetes mellitus]. Clin Ter 1980 0.75
186 Platelet aggregation after strict metabolic control using the artificial pancreas. Diabetologia 1982 0.75
187 Increased red cell volume in impaired glucose tolerance: a further evidence of hematologic sequelae of altered glucose metabolism. Diabetes Care 1985 0.75
188 Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man. J Clin Endocrinol Metab 1979 0.75
189 Somatostatin and insulin secretion in man. I. The effect of phentolamine. Pharmacol Res Commun 1980 0.75
190 Interaction between epinephrine, prostaglandin E, and met-enkephalin in the regulation of insulin release in man. Diabete Metab 1985 0.75
191 Hypertension and diabetes: an hypothesis on the possible role of hyperglycemia. Diabete Metab 1989 0.75
192 Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects. Acta Diabetol Lat 1982 0.75
193 Hemorheological and cardiovascular responses to beta-endorphin and naloxone in healthy subjects and in patients with essential hypertension. J Clin Endocrinol Metab 1994 0.75
194 Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes. Farmaco Prat 1979 0.75
195 Impaired insulin secretion in human diabetes mellitus III. The effect of the serotonin antagonist metergoline. Diabete Metab 1981 0.75
196 Rapid decrease of platelet aggregation (ADP--and collagen--induced) and of platelet circulating aggregates by the artificial pancreas in insulin-dependent diabetics. Diabete Metab 1984 0.75
197 Atypical environmental factor in expressing type I (insulin-dependent) diabetes mellitus. J Endocrinol Invest 1990 0.75
198 Effect of furosemide on insulin and glucagon responses to arginine in normal subjects. Diabetologia 1980 0.75
199 [Consequences of pancreatectomy in a patient with type 2 diabetes mellitus (non-insulin-dependent). Clinico-therapeutic aspects]. G Clin Med 1987 0.75
200 Acetylsalicyclic acid in diabetes. Lancet 1981 0.75
201 [Hyperglycemia and diabetic complications: cause and effect?]. Minerva Endocrinol 1989 0.75
202 Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects. Diabete Metab 1980 0.75
203 Moderate coffee consumption seems to cause no danger for coronary heart disease. Diabete Metab 1990 0.75
204 Plasma endothelin in diabetic autonomic neuropathy. Diabetes Care 1994 0.75
205 Influence of acetylsalicylic acid on insulin, glucagon and growth hormone responses to glucose and arginine in healthy subjects. Farmaco Prat 1979 0.75
206 Acetylsalicylic acid and lysine inhibit protein glycosylation in vitro. A preliminary report. Diabete Metab 1985 0.75
207 [Clinical evaluation of bumetanide in congestive heart failure]. Farmaco Prat 1980 0.75
208 Calcitonin and the human endocrine pancreas. Biomed Pharmacother 1984 0.75
209 Somatostatin and insulin secretion in man. II. The effect of theophylline. Acta Diabetol Lat 1980 0.75
210 Influence of labile glucose adducts on glycosylated protein assay by aminophenylboronic acid affinity chromatography: in vivo studies. Acta Diabetol Lat 1985 0.75
211 [Opioid peptides. Their role in the physiopathology of the endocrine pancreas function]. Minerva Endocrinol 1986 0.75
212 Glycemic control and cardiovascular diseases in Type 2 diabetes mellitus. Beyond fasting glycemia and glycosylated hemoglobin. Diabetes Nutr Metab 2000 0.75
213 Modulation by verapamil of insulin and glucagon secretion in man. Acta Diabetol Lat 1981 0.75
214 Plasma cortisol and growth hormone in reactive hypoglycemia: a reevaluation. Farmaco Prat 1979 0.75
215 Somatostatin and insulin secretion in man. III - Lack of interaction with prostaglandins. Farmaco Sci 1980 0.75
216 Somatostatin and insulin secretion in man. IV. The role of calcium. J Clin Endocrinol Metab 1980 0.75
217 Heterogeneity of diabetes mellitus. Diabetologia 1987 0.75
218 Hyperglycemia-conditioned increase in alpha-2-macroglobulin in healthy normal subjects: a phenomenon correlated with deficient antithrombin III activity. Acta Haematol 1989 0.75
219 Normalization by sodium salicylate of the impaired counterregulatory glucagon response to hypoglycemia in insulin-dependent diabetes. A possible role for endogenous prostaglandins. Diabetes 1985 0.75
220 Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity. Diabetologia 1990 0.75
221 The oxygen-release capacity of red blood cells in insulin-dependent diabetics after artificial pancreas. Acta Diabetol Lat 1985 0.75
222 Arguments for an inhibiting role of prostaglandin E1 on insulin secretion in man. Farmaco Sci 1979 0.75
223 Aspirin and non-enzymatic glycation. Acta Diabetol Lat 1987 0.75
224 Colchicine and insulin secretion in man. Diabetes 1981 0.75
225 Elevated plasma free fatty acid concentrations do not modify cardiac repolarization in patients treated by electrolyte-glucose-insulin infusion. J Endocrinol Invest 2002 0.75
226 The combination of insulin and oral hypoglycaemic drugs: a continuous challenge. Diabete Metab 1993 0.75
227 Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics. Haemostasis 1986 0.75
228 Impaired insulin secretion in human diabetes mellitus. Interactions between naloxone, phentolamine and lysine acetylsalicylate upon glucose induced insulin release. Diabete Metab 1985 0.75
229 [Opiates and non-insulin-dependent diabetes]. Journ Annu Diabetol Hotel Dieu 1986 0.75
230 Plasma C-peptide response to arginine in insulin-dependent diabetic subjects. J Endocrinol Invest 1980 0.75
231 Acetylsalicylic acid augments insulin and C-peptide responses to arginine in diabetes mellitus. Prostaglandins Med 1979 0.75
232 Non-enzymatic glycosylation reduces antithrombin III activity. Thromb Haemost 1984 0.75
233 Does a common mechanism induce diverse complications of diabetes? Diabetes Care 1988 0.75
234 Impaired insulin secretion in human diabetes mellitus. Effect of pharmacological activation of gamma-aminobutyric acid system. Acta Diabetol Lat 1986 0.75
235 Calcitonin, a diabetogenic hormone? J Clin Endocrinol Metab 1981 0.75
236 Sensorimotor evaluation of ano-rectal complex in diabetes mellitus. Diabete Metab 1992 0.75
237 [Correlation between changes in myocardial contraction and the level of circulating hormones in hypothyroid patients. Modifications during substitution therapy]. Minerva Cardioangiol 1981 0.75
238 Is a family history of diabetes associated with an increased level of cardiovascular risk factors? Studies in healthy people and in subjects with different degree of glucose intolerance. Diabete Metab 1993 0.75
239 Effects of vaso-inactive doses of PGA1 and PGE1 on insulin secretion in the rat. Pharmacol Res Commun 1977 0.75
240 Low molecular weight heparin restores antithrombin III activity from hyperglycemia induced alterations. Diabete Metab 1990 0.75
241 Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease. Arch Gerontol Geriatr 2008 0.75
242 Acetylsalicylic acid and glucose metabolism in man: is there a role for prostaglandins? Diabetologia 1986 0.75
243 Effectiveness of treatment of insulin-dependent diabetes with single dose of mixture of three kinds of insulin, employing semisynthetic human insulin. Diabete Metab 1989 0.75
244 Hemodynamic effects of somatostatin in insulin-dependent diabetic subjects. Acta Diabetol Lat 1980 0.75
245 Antioxidants and nitrate tolerance. Circulation 1998 0.75
246 [Usefulness of right heart microcatheterization in hemodynamic evaluation of some heart diseases]. Minerva Cardioangiol 1980 0.75
247 Increased labile hemoglobin glycosylation in opiate addicts: an unclear phenomenon. Diabete Metab 1985 0.75
248 Pathophysiological study of the non-insulin-dependent phase of type I diabetes mellitus. Acta Diabetol Lat 1989 0.75
249 Relationships between growth hormone secretion and microangiophaty in subjects with prediabetes. Farmaco Sci 1979 0.75
250 Glucagon secretion in patients with hypoparathyroidism: effect of serum calcium on glucagon release. J Clin Endocrinol Metab 1982 0.75
251 Circulating endothelial progenitor cells in acromegaly. J Endocrinol Invest 2013 0.75
252 Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics. Int J Clin Pharmacol Ther Toxicol 1983 0.75
253 Comparative effects of metformin and indanorex in the treatment of reactive hypoglycemia. Int J Clin Pharmacol Biopharm 1979 0.75